Akụkọ ụlọ ọrụ
-
Akụkọ na-atọ ụtọ | JYMed's Liraglutide API na-anata Asambodo WC
Na Ọktọba 12, 2024, JYMed's Liraglutide API nwetara akwụkwọ nkwenye Ederede (WC), na-aka akara nzọụkwụ dị oke mkpa maka mbupụ API na-aga nke ọma n'ahịa EU. WC (Nkwenye Ederede)...GỤKWUO -
Ekele JYMed's Tirzepatide emechaala ntinye akwụkwọ US-DMF
JYMed Technology Co., Ltd. nwere obi ụtọ ịkpọsa na ngwaahịa ya, Tirzepatide, emechaala ndebanye aha Drug Master File (DMF) na US FDA (nọmba DMF: 040115) wee nata FDA's Acknowl ...GỤKWUO -
JYMed Peptide na-akpọ gị òkù ka ị gaa ihe ngosi ihe ịchọ mma Korea 2024
Ebe: Korea International Exhibition Center Ụbọchị: Julaị 24-26, 2024 Oge: 10:00 AM - 5:00 Pm okwu: COEX ngosi Center Hall C, 513 Yeongdong-daero, Gangnam-gu, Seoul, 06164 In-ihe ịchọ mma bụ ndị isi mba ngosi ihe ngosi ingren nkeonwe na onye ...GỤKWUO
